673000 Sigma-AldrichVacuolin-1 - CAS 351986-85-1 - Calbiochem
A cell-permeable triazine based compound that inhibits Ca2+-dependent fusion of lysosomes with the plasma membrane and the release of lysosomal content, without affecting enlargeosomes or other membrane-bound organelles.
More>> A cell-permeable triazine based compound that inhibits Ca2+-dependent fusion of lysosomes with the plasma membrane and the release of lysosomal content, without affecting enlargeosomes or other membrane-bound organelles. Less<<Empfohlene Produkte
Übersicht
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
351986-85-1 | C₂₆H₂₄IN₇O |
Preis & Verfügbarkeit
Bestellnummer | Verfügbarkeit | Verpackung | St./Pkg. | Preis | Menge | |
---|---|---|---|---|---|---|
673000-10MG |
|
Glasflasche | 10 mg |
|
— |
References | |
---|---|
References | Cerny, J., et al. 2004. EMBO Rep. 5, 883. |
Product Information | |
---|---|
CAS number | 351986-85-1 |
ATP Competitive | N |
Form | White solid |
Hill Formula | C₂₆H₂₄IN₇O |
Chemical formula | C₂₆H₂₄IN₇O |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Ca2+-dependent fusion of lysosomes with the plasma membrane |
Purity | ≥95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Bestellnummer | GTIN |
673000-10MG | 04055977183511 |
Documentation
Vacuolin-1 - CAS 351986-85-1 - Calbiochem SDB
Titel |
---|
Vacuolin-1 - CAS 351986-85-1 - Calbiochem Analysenzertifikate
Titel | Chargennummer |
---|---|
673000 |
Literatur
Übersicht |
---|
Cerny, J., et al. 2004. EMBO Rep. 5, 883. |